Dillards Cap Tr I - 7.50% SP REDEEM 01/08/2038 USD 25 OverviewTrack Dillards Cap Tr I - 7.50% SP REDEEM 01/08/2038 USD 25's EBIT ($830M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jul 31, 2026
Trailing 12 months ending Jul 31, 2026
The latest EBIT for DDT is $830M as of July 2026. That compares with $700M in the prior-year period — up 19.7% year over year. That is below the Consumer Discretionary sector average of $150B. Investors often review this figure alongside Dillards Cap Tr I - 7.50% SP REDEEM 01/08/2038 USD 25's historical trend and sector peers before judging valuation or financial health.
Over the past year, DDT's EBIT moved from $700M to $830M — a 19.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dillards Cap Tr I - 7.50% SP REDEEM 01/08/2038 USD 25's operating scale or balance-sheet position.
Against Consumer Discretionary companies, DDT currently prints $830M for EBIT, while the sector average sits near $150B. That is roughly 99.4% below the sector mean. Large gaps often invite a closer look at Dillards Cap Tr I - 7.50% SP REDEEM 01/08/2038 USD 25's growth, margins, and balance sheet.
A EBIT figure of $830M for DDT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $150B. Explore the charts below for those layers of context.
After noting DDT's EBIT ($830M), review year-over-year change from $700M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
